The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

The drug company Sandoz, a subsidiary of Novartis International AG, is conducting a voluntary recall of two of its injectable products, according to the FDA. The two lots, CL0996 and CJ4948, are made of methotrexate sodium, an antimetabolite and antifolate. Particulate matters were discovered in the products during an inspection.

The company has not yet reported any adverse affects of the drug, but the FDA warns consumers that microembolization may occur due to the particulate matter. The affected drugs were distributed internationally in the United States and Poland.

Dangerous drug recalls are all too common. A hazardous drug product is a particular risk for consumers who may be taking it, due to the fact that they may already be ill and are taking the drug in order to treat their illness. Particularly considering that Sandoz’s drugs are distributed across such a wide area (in this case, multiple countries), it is critical that they act quickly in ensuring that their drugs are taken off the market before consumers suffer any harm.

May 2013 alone has already seen twenty-one recalls of dangerous food and drugs, so it is important for consumers to be up-to-date and aware of the various products that may be dangerous and unfit for consumption. Checking the FDA’s and various consumer protection agency’s lists often ensures that one has knowledge of which products they should not be using or should return to the manufacturer.

Comments are closed.

Of Interest